Nationwide genomic surveillance of Mpox clade IIb reveals APOBEC3-driven evolution, terminal deletions, and clade Ib introductions

The 2022–2023 global mpox outbreak highlighted the critical need for robust genomic surveillance capabilities to track mpox virus (MPXV) evolution and transmission dynamics. Building upon our established SARS-CoV-2 sequencing infrastructure, we implemented a Molecular Loop ® probe-based long-read sequencing approach using Pacific Biosciences Sequel II technology for comprehensive MPXV genomic surveillance across the United States (US). From August 2024 to June 2025, we generated 326 high-quality whole genome sequences from residual mpox-positive clinical specimens collected by Labcorp across all 10 US Department of Health and Human Services regions. Our analysis identified two samples containing clade Ib MPXV in January and June 2025 and captured shifting trends in clade IIb diversity, with 12 distinct lineages observed. We also identified multiple instances of large (~ 1.6–17.6 kb) deletions proximal to the inverted terminal repeats in clade IIb genomes. APOBEC3 mutation analysis indicated substantial evidence of human-to-human transmission among both clades. Further, we observed significantly higher APOBEC3-associated SNPs per kilobase ( P < 0.001) in clade IIb genomic variable regions relative to their central conserved region. Our assay exhibited strong reproducibility across biological replicates from individual patients and accuracy was confirmed via parallel sequencing of select specimens by US Centers for Disease Control and Prevention (CDC) using metagenomic sequencing. We also demonstrated via custom simulation that our assay discriminates all known MPXV clades and lineages, including those we have not observed in the US. Our integrated nationwide surveillance system facilitates real-time genomic tracking of outbreak evolution, with demonstrated capacity across SARS-CoV-2 and MPXV, positioning this platform for rapid deployment during future pathogen emergence.

Authors

Institutions

Publication Details

Journal
BMC Infectious Diseases
Published
2026-11-19
DOI
https://doi.org/10.1186/s12879-026-14848-5
Primary Topic
Poxvirus research and outbreaks
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Nationwide genomic surveillance of Mpox clade IIb reveals APOBEC3-driven evolution, terminal deletions, and clade Ib introductions

Natalie Britt, Suzanne E. Dale, Deborah Boles, Lakshmanan K. Iyer et al.
4 links
BMC Infectious Diseases
Poxvirus research and outbreaks
article

Nationwide genomic surveillance of Mpox clade IIb reveals APOBEC3-driven evolution, terminal deletions, and clade Ib introductions

Natalie Britt, Suzanne E. Dale, Deborah Boles, Lakshmanan K. Iyer, Jasmine M. Chaitram, Karan Kapuria, Christina L. Hutson, Hayden N. Brochu, Jiusheng Deng, Kuncheng Song, Lydia Peavy, Qiandong Zeng, Qimin Zhang, Qian Shi, Jonathan Williams, D McGrath, Crystal M. Gigante, Ayla B. Harris, James Chappell, Brian M Norvell, Jason Munroe, Nathan J Harris
article en

Abstract

The 2022–2023 global mpox outbreak highlighted the critical need for robust genomic surveillance capabilities to track mpox virus (MPXV) evolution and transmission dynamics. Building upon our established SARS-CoV-2 sequencing infrastructure, we implemented a Molecular Loop ® probe-based long-read sequencing approach using Pacific Biosciences Sequel II technology for comprehensive MPXV genomic surveillance across the United States (US). From August 2024 to June 2025, we generated 326 high-quality whole genome sequences from residual mpox-positive clinical specimens collected by Labcorp across all 10 US Department of Health and Human Services regions. Our analysis identified two samples containing clade Ib MPXV in January and June 2025 and captured shifting trends in clade IIb diversity, with 12 distinct lineages observed. We also identified multiple instances of large (~ 1.6–17.6 kb) deletions proximal to the inverted terminal repeats in clade IIb genomes. APOBEC3 mutation analysis indicated substantial evidence of human-to-human transmission among both clades. Further, we observed significantly higher APOBEC3-associated SNPs per kilobase ( P < 0.001) in clade IIb genomic variable regions relative to their central conserved region. Our assay exhibited strong reproducibility across biological replicates from individual patients and accuracy was confirmed via parallel sequencing of select specimens by US Centers for Disease Control and Prevention (CDC) using metagenomic sequencing. We also demonstrated via custom simulation that our assay discriminates all known MPXV clades and lineages, including those we have not observed in the US. Our integrated nationwide surveillance system facilitates real-time genomic tracking of outbreak evolution, with demonstrated capacity across SARS-CoV-2 and MPXV, positioning this platform for rapid deployment during future pathogen emergence.

BMC Infectious Diseases
Centers for Disease Control and Prevention (US), LabCorp (United States) (US), Centers for Disease Control and Prevention (UG), National Center for Emerging and Zoonotic Infectious Diseases (US), The Centers (US)
Centers for Disease Control and Prevention
Good health and well-being
Poxvirus research and outbreaks
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon